0001628280-22-005790.txt : 20220310 0001628280-22-005790.hdr.sgml : 20220310 20220310183937 ACCESSION NUMBER: 0001628280-22-005790 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220309 FILED AS OF DATE: 20220310 DATE AS OF CHANGE: 20220310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erlander Mark CENTRAL INDEX KEY: 0001651537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 22730469 MAIL ADDRESS: STREET 1: C/O TROVAGENE, INC. STREET 2: 11055 FLINTKOTE AVENUE, SUITE A CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 4 1 wf-form4_164695553669989.xml FORM 4 X0306 4 2022-03-09 0 0001213037 Cardiff Oncology, Inc. CRDF 0001651537 Erlander Mark C/O CARDIFF ONCOLOGY, INC. 11055 FLINTKOTE AVE SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer Stock Options 2.5 2022-03-09 4 A 0 370128 0 A 2032-03-09 Common Stock 370128.0 1185400 D 92,532 vest on 3/09/2023. 7,711 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026. /s/ Mark Erlander 2022-03-10